… of real-world data to investigate the efficacy of anlotinib used alone and in combination with
other agents in advanced NSCLC, with special attention to the combination of anlotinib with …

… may influence the actual efficacy and safety of anlotinib. Third, … the actual data in the real
world. In conclusion, in this retrospective study of a real-world setting, we revealed that anlotinib …

… Furthermore, oral anlotinib therapy during the coronavirus … efficacy and safety of anlotinib
when used alone or with other antineoplastic agents in patients with aNSCLC in a real-world …

… and to monitor post-marketing safety and adverse events. Citation7 In this study, we analyzed
the efficacy and safety of anlotinib in patients with advanced NSCLC in real-world settings. …

… the real-world efficacy and safety of anlotinib-… , efficacy and safety of anlotinib in real-world
clinical applications, and conducted subgroup analysis to compare the efficacy of anlotinib …

… Anlotinib, an antiangiogenic multi-target tyrosine kinase inhibitor (TKI), has shown favorable
anticancer efficacy and acceptable safety … the real-world efficacy and safety of anlotinib in ES…

… The results of this study show that anlotinib is effective in patients with advanced NSCLC …
In conclusion, we elucidated the efficacy and safety of anlotinib in a real-world setting. Anlotinib …

… However, in practice, anlotinib is used not only in third-… anlotinib in SCLC at the frontline.
Therefore, this study aimed to analyze real-world data on anlotinib to evaluate whether anlotinib …

… analyze the efficacy of anlotinib + ICIs are scarce now. Thus, using real medical cases, we
conducted a retrospective study to examine the efficacy and safety of anlotinib combined with …

… The present study was to investigate the real-world efficacy and safety of anlotinib
monotherapy as third-line therapy for elderly patients with advanced non-small cell lung cancer (…